Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial.
Fallah Mehrabadi MH, Hajimoradi M, Es-Haghi A, Kalantari S, Noofeli M, Mokarram AR, Razzaz SH, Taghdiri M, Mokhberalsafa L, Sadeghi F, Mohseni V, Masoumi S, Golmoradi-Zadeh R, Rabiee MH, Solaymani-Dodaran M, Banihashemi SR.
Fallah Mehrabadi MH, et al. Among authors: kalantari s.
Vaccines (Basel). 2024 Nov 5;12(11):1255. doi: 10.3390/vaccines12111255.
Vaccines (Basel). 2024.
PMID: 39591158
Free PMC article.